NOS2 and asthma: Whether this imbalance in L-arginine metabolism results in systemic regulatory responses to control overshooting NOS activity or contributes to associated complications such as inflammation and airway narrowing or remodeling, as suggested for asthma [33–35], needs to be further investigated.